Not investment advice. Educational platform. See Disclaimer.
NYSE: COR
Cencora, Inc.
Healthcare | Medical - Distribution
$296.51-15.25 (-4.89%)as of 2026-07-15 03:07 UTC
Market Cap$57.7B
Volume1.46M
EPS (TTM)$7.96
Cencora, Inc. (NYSE: COR) is a $57.7B medical - distribution company trading at $296.51 (−4.9% today) — 37.2× trailing earnings, yielding 0.76%. Figures from SEC EDGAR and market feeds; updated 2026-07-15 03:07 UTC.
52-Week Range
Low $288.80High $327.99
What Cencora, Inc. does
The company operates in pharmaceutical distribution, competing with other distributors, drug manufacturers, retail pharmacies, and healthcare technology companies. The pharmaceutical and healthcare industries are undergoing consolidation through strategic alliances, which may reduce the company's negotiating power and create competitive pressures. The company extends credit to customers for purchases of pharmaceuticals and other products, with exposure concentrated among major customers and suppliers whose financial instability could materially harm revenues and operations.
The company operates in pharmaceutical distribution, competing with other distributors, drug manufacturers, retail pharmacies, and healthcare technology companies.
What is COR's valuation?
COR trades at $296.51, 37.25× trailing earnings, 19.50× EV/EBITDA, as of 2026-07-15. It carries a 0.76% dividend yield.
When did COR last file with the SEC?
Cencora, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-15. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-15 03:07 UTC. This page is also available as JSON at /api/data?ticker=COR and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for COR and 3,500+ tickers.
